Directori de persones
Luis Brieva Ruiz

Luis Brieva Ruiz

Grau: Doctor/a

973 705 367
lbrieva.lleida.ics(ELIMINAR)@gencat.cat

ResearcherID: http://www.researcherid.com/rid/E-8505-2019

Publicacions

  • Vazquez-Justes, D; Carreño-Gago L; Garcia-Arum, E; Traveset, A; Montoya, J; Ruiz-Pesini, E; Lopez, R; Brieva, L

    Mitochondrial m.13513G > A Point Mutation in ND5 in a 16-Year-Old Man with Leber Hereditary Optic Neuropathy Detected by Next-Generation Sequencing

    Journal of Pediatric Genetics 8 231-234. .

    [doi:10.1055/s-0039-1691812]

  • Gonzalo, H; Nogueras, L; Gil-Sanchez, A; Hervas, JV; Valcheva, P; Gonzalez-Mingot, C; Martin-Gari, M; Canudes, M; Peralta, S; Solana, MJ; Pamplona, R; Portero-Otin, M; Boada, J; Serrano JCE; Brieva, L

    Impairment of Mitochondrial Redox Status in Peripheral Lymphocytes of Multiple Sclerosis Patients

    Frontiers in Neuroscience 13 938-938. .

    [doi:10.3389/fnins.2019.00938]

  • Nogueras, L; Gonzalo, H; Jove, M; Sol, J; Gil-Sanchez, A; Hervas, JV; Valcheva, P; Gonzalez-Mingot, C; Solana, MJ; Peralta, S; Pamplona, R; Brieva, L

    Lipid profile of cerebrospinal fluid in multiple sclerosis patients: a potential tool for diagnosis

    SCIENTIFIC REPORTS 9 11313-11313. .

    [doi:10.1038/s41598-019-47906-x]

  • Oreja-Guevara, C; Ayuso Blanco T; Brieva Ruiz L; Hernández Pérez MÁ; Meca-Lallana, V; Ramió-Torrentà L

    Cognitive Dysfunctions and Assessments in Multiple Sclerosis

    Frontiers in Neurology 10 581-581. .

    [doi:10.3389/fneur.2019.00581]

  • Fernandez, O; Tintore, M; Saiz, A; Calles-Hernandez, MC; Comabella, M; Ramio-Torrenta, L; Oterino, A; Izquierdo, G; Tellez, N; Garcia-Merino JA; Brieva, L; Arnal-Garcia, C; Aladro, Y; Mendibe-Bilbao, MD; Meca-Lallana, JE; Romero-Pinel, L; Martinez-Gines, ML; Arroyo, R; Oreja-Guevara, C; Costa-Frossard, L; Carrascal, P; Rodriguez-Antiguedad, A

    Review of the novelties presented at the 2018 ECTRIMS Congress: 11th Post-ECTRIMS Meeting (II)

    REVISTA DE NEUROLOGIA 68 468-479. .

    [doi:10.33588/rn.6811.2019121]

  • Fernandez, O; Tintore, M; Saiz, A; Calles-Hernandez, MC; Comabella, M; Ramio-Torrenta, L; Oterino, A; Izquierdo G; Tellez, N; Garcia-Merino JA; Brieva, L; Arnal-Garcia, C; Aladro, Y; Mendibe-Bilbao, MD; Meca-Lallana, JE; Romero-Pinel, L; Martinez-Gines, ML; Arroyo, R; Oreja-Guevara, C; Costa-Frossard, L; Carrascal, P; Rodriguez-Antiguedad, A

    Review of the novelties presented at the 2018 ECTRIMS Congress: 11th Post-ECTRIMS Meeting (I)

    REVISTA DE NEUROLOGIA 68 431-441. .

    [doi:10.33588/rn.6810.2019120]

  • Hervas-Garcia, JV; Ramio-Torrenta, L; Brieva-Ruiz, L; Batlle-Nadal, J; Moral, E; Blanco, Y; Cano-Orgaz, A; Presas-Rodriguez, S; Torres, F; Capellades, J; Ramo-Tello, C

    Comparison of two high doses of oral methylprednisolone for multiple sclerosis relapses: a pilot, multicentre, randomized, double-blind, non-inferiority trial

    EUROPEAN JOURNAL OF NEUROLOGY 26 525-532. .

    [doi:10.1111/ene.13851]

  • González Mingot C; Juárez Turégano A; Bosch Gaya A; Brieva Ruiz L

    Cardiogenic shock in clinically isolated syndrome

    NEUROLOGIA 34 69-72. .

    [doi:10.1016/j.nrl.2017.03.008]

  • Quirant-Sanchez, B; Presas-Rodriguez, S; Mansilla, MJ; Teniente-Serra, A; Hervas-Garcia, JV; Brieva, L; Moral-Torres, E; Cano, A; Munteis, E; Navarro-Barriuso, J; Martinez-Caceres, EM; Ramo-Tello, C

    Th1Th17(CM) Lymphocyte Subpopulation as a Predictive Biomarker of Disease Activity in Multiple Sclerosis Patients under Dimethyl Fumarate or Fingolimod Treatment

    Mediators of Inflammation 2019 8147803-8147803. .

    [doi:10.1155/2019/8147803]

  • Sepulveda, M; Aldea, M; Escudero, D; Llufriu, S; Arrambide, G; Otero-Romero, S; Sastre-Garriga, J; Romero-Pinel, L; Martinez-Yelamos, S; Sola-Valls, N; Armangue, T; Sotoca, J; Escartin, A; Robles-Cedeno, R; Ramio-Torrent, L; Presas-Rodriguez, S; Ramo-Tello, C; Munteis, E; Pelayo, R; Gubieras, L; Brieva, L; Ortiz, N; Hervas, M; Mañé-Martínez MA; Cano, A; Vela, E; Tintore, M; Blanco, Y; Montalban, X; Graus, F; Saiz, A

    Epidemiology of NMOSD in Catalonia: Influence of the new 2015 criteria in incidence and prevalence estimates

    MULTIPLE SCLEROSIS JOURNAL 24 1843-1851. .

    [doi:10.1177/1352458517735191]

  • Quirant-Sanchez, B; Hervas-Garcia, JV; Teniente-Serra, A; Brieva, L; Moral-Torres, E; Cano, A; Munteis, E; Mansilla, MJ; Presas-Rodriguez, S; Navarro-Barriuso, J; Ramo-Tello, C; Martinez-Caceres, EM

    Predicting therapeutic response to fingolimod treatment in multiple sclerosis patients

    Cns Neuroscience & Therapeutics 24 1175-1184. .

    [doi:10.1111/cns.12851]

  • Gil, A; Pardinas, B; Hervas, V; Lecina, J; Solana, MJ; Peralta, S; Forne, C; Gonzalez, C; Gonzalo, H; Nogueras, L; Brieva, L

    Pilot Study of Telemedicine in multiple sclerosis to evaluate the effectiveness of a telecommunication system for the detection of the clinical activity of the disease in the number of relapses with respect to the standard clinical practice. TELEM

    MULTIPLE SCLEROSIS JOURNAL 24 795-796. .

Projectes

  • EMCOVID-19: Esclerosis Múltiple y COVID-19
  • "Registro de pacientes con esclerosis múltiple (EM) tratados con Natalizumab en España"
  • UTILIDAD DE LA REALIZACION DE SECUENCIAS DE DIFUSION Y LA DETERMINACION DE BIOMARCADORES EN EL PRONOSTICO DE LOS PACIENTES CON UN ATAQUE ISQUEMICO TRANSITORIO